- Home
- NUTX
NUTX
Nutex Health Inc.
as 04-25-2025 3:40pm EST
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | HOUSTON |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $80.00 | AVG Volume (30 days): | 148.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 9.71 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.16 - $152.51 | Next Earning Date: | 05-07-2025 |
| Revenue: | $479,948,633 | Revenue Growth: | 93.80% |
| Revenue Growth (this year): | -12.76% | Revenue Growth (next year): | 13.03% |
Stock Insider Trading Activity of Nutex Health Inc. (NUTX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Bates Jon Christian | NUTX | Chief Financial Officer | Mar 1 '25 | Buy | $81.81 | 1,000 | $81,810.00 | 4,888 |
Latest Nutex Health Inc. News
NUTX Breaking Stock News: Dive into NUTX Ticker-Specific Updates for Smart Investing
Argus Research
11 days ago
Daily – Vickers Top Buyers & Sellers for 04/15/2025
Simply Wall St.
24 days ago
US Market's Undiscovered Gems Including Nutex Health Among Top Small Caps
GuruFocus.com
24 days ago
Nutex Health Inc (NUTX) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Expansion
PR Newswire
25 days ago
NUTEX HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
PR Newswire
a month ago
NUTEX HEALTH RESCHEDULES EARNINGS RELEASE AND CONFERENCE CALL
PR Newswire
a month ago
Nutex Health to Present at the EDPMA Solutions Summit 2025
PR Newswire
a month ago
NUTEX HEALTH SCHEDULES 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS RELEASE AND CONFERENCE CALL
Simply Wall St.
a month ago
Spotlight On Nutex Health And 2 Other Leading Growth Stocks With Insider Stake
Compare NUTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NUTX Nutex Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.